Thanks to its experimental gene therapy injection for COVID-19, in 2022, Pfizer became the first drug company in history to break $100 billion in annual sales.1 But its mere existence didn’t ensure Pfizer’s success.
Read more: https://greenmedinfo.com/blog/how-pfizer-bribes-led-vaccine-mandates
